• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因检测时代的肌营养不良症肌肉活检:一个中心的数据。

Dystrophinopathy muscle biopsies in the genetic testing ERA: One center's data.

作者信息

Carlson Courtney R, Moore Steven A, Mathews Katherine D

机构信息

University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.

Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

出版信息

Muscle Nerve. 2018 Jan 24. doi: 10.1002/mus.26083.

DOI:10.1002/mus.26083
PMID:29365344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6057846/
Abstract

INTRODUCTION

Comprehensive genetic testing for dystrophinopathy can detect ∼95% of pathogenic variants in the dystrophin gene (DMD) and is often the preferred diagnostic approach.

METHODS

We reviewed pathology reports for muscle biopsies evaluated at the University of Iowa with a pathological diagnosis of dystrophinopathy based on dystrophic histopathology and abnormal immunofluorescence staining: reduced to absent dystrophin, expression of utrophin, and loss of neuronal nitric oxide synthase.

RESULTS

The percentage of muscle biopsies with dystrophinopathy has been stable since 1997. Among 2,298 biopsies evaluated between 2011 and 2016, 72 (3.1%) had pathologic features of dystrophinopathy. Median age at biopsy was 8 years (range, 0.66-84). Half had undergone DMD genetic testing prior to biopsy. Clinical phenotypes recorded on requisitions were typical of muscular dystrophy for 57 (79%) biopsies.

DISCUSSION

Muscle biopsy continues to play an important role in the diagnosis of dystrophinopathy, particularly in patients with later symptom onset, comorbidities, or normal DMD genetic testing results. Muscle Nerve, 2018.

摘要

引言

对肌营养不良症进行全面的基因检测可检测出肌营养不良蛋白基因(DMD)中约95%的致病变异,这通常是首选的诊断方法。

方法

我们回顾了爱荷华大学评估的肌肉活检病理报告,这些活检基于营养不良性组织病理学和异常免疫荧光染色,病理诊断为肌营养不良症:肌营养不良蛋白减少至缺失、抗肌萎缩蛋白表达以及神经元型一氧化氮合酶缺失。

结果

自1997年以来,患有肌营养不良症的肌肉活检比例一直保持稳定。在2011年至2016年评估的2298例活检中,72例(3.1%)具有肌营养不良症的病理特征。活检时的中位年龄为8岁(范围为0.66 - 84岁)。其中一半在活检前接受了DMD基因检测。申请单上记录的临床表型在57例(79%)活检中为典型的肌肉营养不良症。

讨论

肌肉活检在肌营养不良症的诊断中继续发挥重要作用,特别是在症状出现较晚、有合并症或DMD基因检测结果正常的患者中。《肌肉与神经》,2018年。

相似文献

1
Dystrophinopathy muscle biopsies in the genetic testing ERA: One center's data.基因检测时代的肌营养不良症肌肉活检:一个中心的数据。
Muscle Nerve. 2018 Jan 24. doi: 10.1002/mus.26083.
2
Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.杜兴氏和贝克氏肌营养不良症肌肉活检中肌养蛋白水平与抗肌萎缩蛋白复合体及肌纤维再生的相关性
PLoS One. 2016 Mar 14;11(3):e0150818. doi: 10.1371/journal.pone.0150818. eCollection 2016.
3
Pathological Issues in Dystrophinopathy in the Age of Genetic Therapies.基因治疗时代肌营养不良症中的病理问题。
Annu Rev Pathol. 2019 Jan 24;14:105-126. doi: 10.1146/annurev-pathmechdis-012418-012945. Epub 2018 Aug 27.
4
Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.缺乏神经元型一氧化氮合酶(nNOS)作为诊断具有杆状结构域缺失的贝克型肌营养不良症的病理标志物。
Neuropathol Appl Neurobiol. 2004 Oct;30(5):540-5. doi: 10.1111/j.1365-2990.2004.00561.x.
5
Utility of dystrophin and utrophin staining in childhood muscular dystrophy.抗肌萎缩蛋白和肌营养蛋白染色在儿童期肌营养不良中的应用
Indian J Pathol Microbiol. 2004 Jul;47(3):367-9.
6
Increase in cathepsin K gene expression in Duchenne muscular dystrophy skeletal muscle.杜氏肌营养不良症骨骼肌中组织蛋白酶 K 基因表达增加。
Neuropathology. 2024 Dec;44(6):411-421. doi: 10.1111/neup.12995. Epub 2024 Jul 16.
7
High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients.高通量数字图像分析揭示了不同杜氏肌营养不良症患者中肌营养不良蛋白表达的独特模式。
J Neuropathol Exp Neurol. 2021 Oct 26;80(10):955-965. doi: 10.1093/jnen/nlab088.
8
Automated immunofluorescence analysis for sensitive and precise dystrophin quantification in muscle biopsies.自动化免疫荧光分析可灵敏、精确地定量肌肉活检中的抗肌萎缩蛋白。
Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12785. doi: 10.1111/nan.12785. Epub 2021 Dec 28.
9
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies.肌萎缩蛋白调节剂类药物作为杜氏肌营养不良症和贝克肌营养不良症的潜在治疗方法。
Neuropathol Appl Neurobiol. 2021 Oct;47(6):711-723. doi: 10.1111/nan.12735. Epub 2021 Jun 4.
10
Immunohistochemical localization of utrophin and other cytoskeletal proteins in skin smooth muscle in neuromuscular diseases.神经营养性疾病中皮肤平滑肌内肌养蛋白及其他细胞骨架蛋白的免疫组织化学定位
J Neurol Sci. 1996 Nov;143(1-2):156-60. doi: 10.1016/s0022-510x(96)00210-9.

引用本文的文献

1
Neurosurgical Intervention for Nerve and Muscle Biopsies.神经和肌肉活检的神经外科干预
Diagnostics (Basel). 2024 May 31;14(11):1169. doi: 10.3390/diagnostics14111169.
2
Development and Validation of an Outpatient Clinical Predictive Score for the Diagnosis of Duchenne Muscular Dystrophy/Becker Muscular Dystrophy in Children Aged 2-18 Years.2至18岁儿童杜氏肌营养不良症/贝克肌营养不良症门诊临床诊断预测评分的开发与验证
Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):453-460. doi: 10.4103/aian.aian_20_23. Epub 2023 Jun 12.
3
A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring.一项原理验证蛋白质组学研究在人血浆中检测到肌营养不良蛋白:在 DMD 诊断和临床监测中的意义。
Int J Mol Sci. 2023 Mar 8;24(6):5215. doi: 10.3390/ijms24065215.
4
What Every Neuropathologist Needs to Know: The Muscle Biopsy.每个神经病理学家都需要知道的事:肌肉活检。
J Neuropathol Exp Neurol. 2020 Jul 1;79(7):719-733. doi: 10.1093/jnen/nlaa046.

本文引用的文献

1
Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Confirmed by Multiplex Ligation-Dependent Probe Amplification: Genotype-Phenotype Correlation in a Large Cohort.多重连接依赖探针扩增法确诊杜氏肌营养不良症和贝克肌营养不良症:一个大型队列中的基因型-表型相关性
J Clin Neurol. 2017 Jan;13(1):91-97. doi: 10.3988/jcn.2017.13.1.91.
2
The importance of genetic diagnosis for Duchenne muscular dystrophy.杜氏肌营养不良症基因诊断的重要性。
J Med Genet. 2016 Mar;53(3):145-51. doi: 10.1136/jmedgenet-2015-103387. Epub 2016 Jan 11.
3
Modifier genes and their effect on Duchenne muscular dystrophy.修饰基因及其对杜氏肌营养不良症的影响。
Curr Opin Neurol. 2015 Oct;28(5):528-34. doi: 10.1097/WCO.0000000000000240.
4
Prevalence of Duchenne and Becker muscular dystrophies in the United States.美国杜氏和贝克肌营养不良症的患病率。
Pediatrics. 2015 Mar;135(3):513-21. doi: 10.1542/peds.2014-2044. Epub 2015 Feb 16.
5
Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.循证指南摘要:肢带型和远端型肌营养不良症的诊断与治疗:美国神经病学学会指南制定小组委员会及美国神经肌肉与电诊断医学协会实践问题审查小组报告
Neurology. 2014 Oct 14;83(16):1453-63. doi: 10.1212/WNL.0000000000000892.
6
Progressive muscular dystrophies.进行性肌营养不良症
Handb Clin Neurol. 2013;113:1343-66. doi: 10.1016/B978-0-444-59565-2.00006-X.
7
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.杜氏肌营养不良症的诊断和管理,第 1 部分:诊断、药理学和心理社会管理。
Lancet Neurol. 2010 Jan;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27.
8
Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.DMD 基因突变在肌营养不良症患者中的突变谱:现代诊断技术在大样本中的应用。
Hum Mutat. 2009 Dec;30(12):1657-66. doi: 10.1002/humu.21114.
9
Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).杜氏肌营养不良症的延迟诊断:来自肌肉萎缩症监测、追踪与研究网络(MD STARnet)的数据。
J Pediatr. 2009 Sep;155(3):380-5. doi: 10.1016/j.jpeds.2009.02.007. Epub 2009 Apr 25.
10
Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase.利用UMD-DMD数据库对2405例肌营养不良症患者进行基因型-表型分析:一个全国性知识库模型
Hum Mutat. 2009 Jun;30(6):934-45. doi: 10.1002/humu.20976.